Cecilia Sgadari

5.7k total citations · 1 hit paper
68 papers, 4.2k citations indexed

About

Cecilia Sgadari is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Cecilia Sgadari has authored 68 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 21 papers in Immunology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Cecilia Sgadari's work include Viral-associated cancers and disorders (28 papers), Lymphoma Diagnosis and Treatment (19 papers) and HIV Research and Treatment (15 papers). Cecilia Sgadari is often cited by papers focused on Viral-associated cancers and disorders (28 papers), Lymphoma Diagnosis and Treatment (19 papers) and HIV Research and Treatment (15 papers). Cecilia Sgadari collaborates with scholars based in Italy, United States and Germany. Cecilia Sgadari's co-authors include Giovanna Tosato, Barbara Ensoli, Giovanni Barillari, Anne Angiolillo, Paolo Monini, Joshua Μ. Farber, Fang Liao, Julie Teruya‐Feldstein, Michael Stürzl and Gregory H. Reaman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Cecilia Sgadari

68 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.

1995 594 citations Anne Angiolillo, Cecilia Sgadari et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Cecilia Sgadari

Since Specialization

Citations

This map shows the geographic impact of Cecilia Sgadari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Sgadari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Sgadari more than expected).

Fields of papers citing papers by Cecilia Sgadari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Sgadari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Sgadari. The network helps show where Cecilia Sgadari may publish in the future.

Co-authorship network of co-authors of Cecilia Sgadari

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Sgadari. A scholar is included among the top collaborators of Cecilia Sgadari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Sgadari. Cecilia Sgadari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly 2024 ·Cancer Research Communications ·Cecilia Sgadari, (unknown), Orietta Picconi, Antonella Tripiciano, Francesca Maria Gaiani, Vittorio Francavilla, Angela Arancio, (unknown), Clelia Palladino, Sonia Moretti, Paolo Monini, Lucia Brambilla, Barbara Ensoli	2
2	HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction 2020 ·Molecular Cancer Therapeutics ·Yaqi Qiu, Federica Maione, (unknown), Claudia Meda, Orietta Picconi, (unknown), Alberto Pisacane, Anna Sapino, Clelia Palladino, Giovanni Barillari, Paolo Monini, Federico Bussolino, Barbara Ensoli, Cecilia Sgadari, Enrico Giraudo	10
3	Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells 2017 ·Oncology Letters ·Ilaria Bacigalupo, Clelia Palladino, Patrizia Leone, Elena Toschi, Cecilia Sgadari, Barbara Ensoli, Giovanni Barillari	11
4	Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine 2015 ·Expert Opinion on Biological Therapy ·Aurelio Cafaro, Antonella Tripiciano, Cecilia Sgadari, Stefania Bellino, Orietta Picconi, Olimpia Longo, Vittorio Francavilla, Stefano Buttò, Fausto Titti, Paolo Monini, Fabrizio Ensoli, Barbara Ensoli	14
5	Pharmacological management of Kaposi's sarcoma 2011 ·Expert Opinion on Pharmacotherapy ·Cecilia Sgadari, Ilaria Bacigalupo, Giovanni Barillari, Barbara Ensoli	9
6	HIV-1 Tat-Based Vaccines: An Overview and Perspectives in the Field of HIV/AIDS Vaccine Development 2009 ·International Reviews of Immunology ·Antonella Caputo, Riccardo Gavioli, Stefania Bellino, Olimpia Longo, Antonella Tripiciano, Vittorio Francavilla, Cecilia Sgadari, Giovanni Paniccia, Fausto Titti, Aurelio Cafaro, Flavia Ferrantelli, Paolo Monini, Fabrizio Ensoli, Barbara Ensoli	26
7	Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir 2009 ·AIDS ·Paolo Monini, Cecilia Sgadari, (unknown), Stefania Bellino, Antonio Di Biagio, Elena Toschi, Ilaria Bacigalupo, Michela Sabbatucci, (unknown), (unknown), Patrizia Leone, Barbara Ensoli	26
8	Evaluation of a Self-Inactivating Lentiviral Vector Expressing Simian Immunodeficiency Virus Gag for Induction of Specific Immune Responses in Vitro and in Vivo 2006 ·Viral Immunology ·Viviana Buffa, Donatella Negri, Pasqualina Leone, Martina Borghi, Roberta Bona, Zuleika Michelini, (unknown), Cecilia Sgadari, Barbara Ensoli, Andrea Cara	28
9	HIV-1 Tat Regulates Endothelial Cell Cycle Progression via Activation of the Ras/ERK MAPK Signaling Pathway 2006 ·Molecular Biology of the Cell ·Elena Toschi, Ilaria Bacigalupo, Raffaele Strippoli, Chiara Chiozzini, Anna Cereseto, Mario Falchi, Filomena Nappi, Cecilia Sgadari, Giovanni Barillari, Fabrizio Mainiero, Barbara Ensoli	65
10	Antitumour effects of antiretroviral therapy 2004 ·Nature reviews. Cancer ·Paolo Monini, Cecilia Sgadari, Elena Toschi, Giovanni Barillari, Barbara Ensoli	94
11	Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth 2003 ·The Lancet Oncology ·Cecilia Sgadari, Paolo Monini, Giovanni Barillari, Barbara Ensoli	122
12	Activation of Matrix-Metalloproteinase-2 and Membrane-Type-1-Matrix-Metalloproteinase in Endothelial Cells and Induction of Vascular Permeability In Vivo by Human Immunodeficiency Virus-1 Tat Protein and Basic Fibroblast Growth Factor 2001 ·Molecular Biology of the Cell ·Elena Toschi, Giovanni Barillari, Cecilia Sgadari, Ilaria Bacigalupo, Anna Cereseto, Davide Carlei, Clelia Palladino, Christian Zietz, Patrizia Leone, Michael Stürzl, Stefano Buttò, Aurelio Cafaro, Paolo Monini, Barbara Ensoli	78
13	Serum Concentrations of Fibroblast Growth Factor 2 Are Increased in HIV Type 1-Infected Patients and Inversely Related to Survival Probability 2001 ·AIDS Research and Human Retroviruses ·Gudrun Ascherl, Cecilia Sgadari, Roberto Bugarini, Johannes R. Bogner, (unknown), Barbara Ensoli, Michael Stürzl	23
14	IFN-γ Induces Endothelial Cells to Proliferate and to Invade the Extracellular Matrix in Response to the HIV-1 Tat Protein: Implications for AIDS-Kaposi’s Sarcoma Pathogenesis 1999 ·The Journal of Immunology ·Valeria Fiorelli, Giovanni Barillari, Elena Toschi, Cecilia Sgadari, Paolo Monini, Michael Stürzl, Barbara Ensoli	49
15	A Role for the Interferon‐Inducible Protein 10 in Inhibition of Angiogenesis by Interleukin‐12 1996 ·Annals of the New York Academy of Sciences ·Anne Angiolillo, Cecilia Sgadari, Giovanna Tosato	94
16	Infection of human endothelial cells with Epstein-Barr virus. 1995 ·The Journal of Experimental Medicine ·Kristine Jones, Constantino Fernández Rivera, Cecilia Sgadari, Janet Franklin, Edward E. Max, Kishor Bhatia, Giovanna Tosato	63
17	Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. breakdown → 1995 ·The Journal of Experimental Medicine ·Anne Angiolillo, Cecilia Sgadari, D D Taub, Fang Liao, Joshua Μ. Farber, (unknown), Hynda K. Kleinman, Gregory H. Reaman, Giovanna Tosato	594
18	8 Epstein-Barr virus as an agent of haematological disease 1995 ·Baillière s Clinical Haematology ·Giovanna Tosato, K Taga, Anne Angiolillo, Cecilia Sgadari	20
19	Single Daily Dose Ceftriaxone Plus Amikacin Treatment of Febrile Episodes in Neutropenic Patients Attending Day Hospital for Hematologic Malignancies 1992 ·Oncology ·Pietro Martino, Corrado Girmenia, Ruggero Raccah, Alessandra Micozzi, Giuseppe Cimino, Cecilia Sgadari, Giuseppe Gentile	32
20	High serum IL‐2 levels are predictive of prolonged survival in multiple myeloma 1990 ·British Journal of Haematology ·Giuseppe Cimino, Giuseppe Avvisati, Sergio Amadori, (unknown), Diana Giannarelli, (unknown), (unknown), Maria Teresa Petrucci, (unknown), Cecilia Sgadari, Franco Mandelli	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact